The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. J of Skin 2020, 4 (6), s93. https://doi.org/10.25251/skin.4.supp.93.